HOME >> MEDICINE >> NEWS
Carnegie Mellon, Pitt demo technology to help elderly at CAST exhibition in Washington

In conjunction with the once-in-a-decade White House Conference on Aging, Carnegie Mellon University and University of Pittsburgh researchers will demonstrate new technologies to enhance the lives of the elderly at the Center for Aging Services Technologies (CAST) exhibition, Dec. 1214, in Washington, D.C.

The researchers will showcase their technologies at a booth in the Imagine Technology Pavilion at the Marriott Wardman Park Hotel, 2660 Woodley Park Road N.W. They are among representatives from 32 companies and research universities participating in the exhibition.

The Carnegie Mellon/Pitt display will include:

  • Pearl the Nursebot, a robot designed to interact with and guide people in assisted living facilities. Pearl is currently undergoing field trials in the Pittsburgh area.
  • Guido, an intelligent walker that provides navigation assistance and collision avoidance for people who need a mobility aid and who also have impaired vision.
  • CareMedia, a video-monitoring technology that can help to pinpoint physiological and behavioral changes among patients in skilled nursing facilities who suffer from Alzheimer's disease or dementia. The system captures video material from more than three-dozen cameras running continuously in the public spaces of these facilities and can automatically detect and catalog various movements, activities and behaviors.
  • SMARTWheel, a wheelchair wheel that collects data as it moves, including the average force it takes to propel itself, frequency and length of each push on the handwheels, and the ease of propelling a given wheelchair. The SMARTWheel is commercially available from Three Rivers Out-Front.
  • GameCycle, an exercise device that promotes physical fitness for people with lower-extremity impairment. The device consists of a videogame console interfaced with an arm cycle, which is used to control a racing game. The GameCycle is also commercially available from
    '"/>



12-Dec-2005


Page: 1 2 3

Related medicine news :

1. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University
2. Carnegie Mellon professors question advice for nuclear attacks
3. Carnegie Mellon researcher wins prestigious career award for NSF
4. Study by Childrens Hospital and Carnegie Mellon explains crucial deficit in children with autism
5. Carnegie Mellon receives NIMH/NSF grant to examine mechanisms that underlie neuronal synchronization
6. Carnegie Mellon, Ohio State get grant to study link between antidepressants and suicidality in teens
7. Carnegie Mellon study demonstrates that lower income, education lead to greater stress levels
8. Carnegie Mellon researchers say use of switchgrass could solve energy woes
9. Carnegie Mellon receives grant to study security issues
10. Teens unaware of sexually transmitted diseases until they catch one, Carnegie Mellon study finds
11. Carnegie Mellon psychologist receives NIH grant

Post Your Comments:
(Date:12/22/2014)... CA (PRWEB) December 22, 2014 The ... PALS, BLS and ACLS online certification provider, are proud ... http://www.acls-pals-bls.com . The updated site now features a more ... than ever to use. , As a company ... information is now consolidated into a single page during ...
(Date:12/22/2014)... 22, 2014 The holidays are here, and ... season. Many may be thinking about how to enjoy these ... few weeks. Health Republic Insurance of New York has compiled ... Chernus, to provide some smart ideas to enjoy the holiday ... 1)    Avoid arriving at a holiday gathering over-hungry , Have a ...
(Date:12/22/2014)... 19, 2014 (HealthDay News) -- U.S. and state health ... apples that has killed at least four people and ... not eat any commercially produced, prepackaged caramel apples until ... Control and Prevention said in a news release. ... had been infected with the outbreak strains of the ...
(Date:12/22/2014)... Physicians in China are most eagerly awaiting a ... lymphoma (NHL), according to a new report from ... MabThera is the only biologic available to treat diffuse ... NHL. , According to Kantar Health’s report, “Biosimilars in ... in China has been growing and is expected to ...
(Date:12/22/2014)... 22, 2014 Super Saturday, the last ... year as the busiest day in the 2014 holiday ... Grass Station had a steady pre-Christmas stream of customers, ... past Saturday. , “I definitely intend to take advantage…of ... Denver resident who was enjoying The Grass Station’s holiday ...
Breaking Medicine News(10 mins):Health News:ACLS Online Certification Website ACLS-PALS-BLS.com Now Features a New and User-Friendly Layout 2Health News:Health Republic Insurance of New York Offers Five Simple Tips to Eat Healthy During the Holidays 2Health News:CDC Warns of Listeria Danger From Caramel Apples 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 3Health News:Customers at Colorado’s Grass Station Say They’re Enjoying the Experience of Legally Purchasing Marijuana this Year to Give as Christmas Presents to Friends and Family 2
(Date:12/22/2014)... and STOCKHOLM , Dec. 22, 2014 ... partner Auxilium Pharmaceuticals, Inc. today announced that the Committee ... European Medicines Agency (EMA) has adopted a positive opinion ... the treatment of adult men with Peyronie,s disease with ... 30 degrees at the start of therapy. ...
(Date:12/22/2014)... Dec. 22, 2014  Relmada Therapeutics, Inc. (OTCQB: ... the treatment of chronic pain, announced today that ... in a pharmacokinetic and pharmacodynamic study with d-Methadone, ... pain. Racemic methadone is a long-acting ... states and substitution therapy in opioid addiction.  It ...
(Date:12/19/2014)... -- You,re visiting the dentist for what you think ... she says you need a root canal. Though it,s ... several questions and feel apprehensive about your upcoming procedure. ... to worry about. The Pennsylvania Dental Association (PDA) wants ... the public may have surrounding this common procedure that ...
Breaking Medicine Technology:Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 2Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 3Root Canals Have Become More Routine 2
Cached News: